The board of directors of medical technology company CONMED Corporation (NASDAQ:CNMD) authorised a quarterly dividend of USD0.20 per share of the company's stock, it declared on Friday.
Shareholders of record as of 13 September 2019 will receive the cash dividend on 7 October 2019.
CONMED provides surgical devices and equipment for minimally invasive procedures.
According to CONMED, its products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development